Ad5-nCoV
The Latest
-
First Human Trial Finds Made-in-China COVID-19 Vaccine Is Safe
A COVID-19 vaccine developed by a Chinese company based in Tianjin is the first in the world to exit a Phase I clinical trial and the first to enter Phase II. 
A COVID-19 vaccine developed by a Chinese company based in Tianjin is the first in the world to exit a Phase I clinical trial and the first to enter Phase II.
